Résultat(s) 1 - 11 résultats de 11 pour la requête '"mostly limited"', Temps de recherche: 0,02s Affiner les résultats
  1. 1
    Multivariate analysis between DENV and CHIKV seroconversion and selected risk factors.

    Multivariate analysis between DENV and CHIKV seroconversion and selected risk factors. par Bethel Alebel Bayrau (22676588)

    Publié 2025
    Sujets:
    Ajouter aux favoris
    Enregistré dans:
  2. 2
    Seroprevalence of DENV and CHIKV among study participants in Kisumu and Ukunda, Kenya, Dec 2019 – Feb 2022.

    Seroprevalence of DENV and CHIKV among study participants in Kisumu and Ukunda, Kenya, Dec 2019 – Feb 2022. par Bethel Alebel Bayrau (22676588)

    Publié 2025
    Sujets:
    Ajouter aux favoris
    Enregistré dans:
  3. 3
    Descriptive statistics and demographics of study participants, Ukunda and Kisumu sites, Kenya, Dec 2019–Feb 2022.

    Descriptive statistics and demographics of study participants, Ukunda and Kisumu sites, Kenya, Dec 2019–Feb 2022. par Bethel Alebel Bayrau (22676588)

    Publié 2025
    Sujets:
    Ajouter aux favoris
    Enregistré dans:
  4. 4
    DENV and CHIKV IgG serology and RT-PCR test results among overall study population and individual study sites Ukunda and Kisumu, Kenya, Dec 2019–Feb 2022.

    DENV and CHIKV IgG serology and RT-PCR test results among overall study population and individual study sites Ukunda and Kisumu, Kenya, Dec 2019–Feb 2022. par Bethel Alebel Bayrau (22676588)

    Publié 2025
    Sujets:
    Ajouter aux favoris
    Enregistré dans:
  5. 5
    Univariate analysis between DENV and CHIKV seropositivity and selected risk factors.

    Univariate analysis between DENV and CHIKV seropositivity and selected risk factors. par Bethel Alebel Bayrau (22676588)

    Publié 2025
    Sujets:
    Ajouter aux favoris
    Enregistré dans:
  6. 6
    Seroconversion of DENV and CHIKV among study participants in Kisumu and Ukunda, Kenya, Dec 2019 – Feb 2022.

    Seroconversion of DENV and CHIKV among study participants in Kisumu and Ukunda, Kenya, Dec 2019 – Feb 2022. par Bethel Alebel Bayrau (22676588)

    Publié 2025
    Sujets:
    Ajouter aux favoris
    Enregistré dans:
  7. 7
    Kaplan Meier survival curves for new CHIKV seropositivity during the 2- year study period from Dec 2019 – Feb 2022.

    Kaplan Meier survival curves for new CHIKV seropositivity during the 2- year study period from Dec 2019 – Feb 2022. par Bethel Alebel Bayrau (22676588)

    Publié 2025
    Sujets:
    Ajouter aux favoris
    Enregistré dans:
  8. 8
    Kaplan Meier survival curves for new DENV seropositivity during the 2-year study period from Dec 2019 – Feb 2022..

    Kaplan Meier survival curves for new DENV seropositivity during the 2-year study period from Dec 2019 – Feb 2022.. par Bethel Alebel Bayrau (22676588)

    Publié 2025
    Sujets:
    Ajouter aux favoris
    Enregistré dans:
  9. 9
    Multivariate analysis between DENV and CHIKV seropositivity and selected risk factors.

    Multivariate analysis between DENV and CHIKV seropositivity and selected risk factors. par Bethel Alebel Bayrau (22676588)

    Publié 2025
    Sujets:
    Ajouter aux favoris
    Enregistré dans:
  10. 10
    Univariate analysis between DENV and CHIKV seroconversion and selected risk factors.

    Univariate analysis between DENV and CHIKV seroconversion and selected risk factors. par Bethel Alebel Bayrau (22676588)

    Publié 2025
    Sujets:
    Ajouter aux favoris
    Enregistré dans:
  11. 11
    Distribution of DENV and CHIKV seroprevalence by age group of participants in the study.

    Distribution of DENV and CHIKV seroprevalence by age group of participants in the study. par Bethel Alebel Bayrau (22676588)

    Publié 2025
    Sujets:
    Ajouter aux favoris
    Enregistré dans:

Outils de recherche: